Developer docs
API playgroundTry for free, no card

Search company profiles

Letco

Full company profile

uuid000d494

Namestring
Letco
Legal namestring
Letco
Company typeenum
Private
Founded yearint
1993
Descriptiontext

Letco (also operating as Letco Med or Letco Medical) is a U.S. pharmaceutical ingredient and compounding supply distributor founded in 1993, operating as an affiliate of Fagron North America. The company sells pharmaceutical-grade chemicals, active pharmaceutical ingredients (APIs), bases and vehicles, capsules, compounding equipment, cleanroom supplies, personal protective equipment (PPE), and specialized dispensing devices to licensed compounding pharmacies and compounding laboratories across the United States. Its product portfolio spans more than a dozen categories including controlled substances, flavors, colorants, excipients, sterile devices (vials, filters, syringes), and branded dosing systems such as Topi-CLICK and Topi-Pump. Distribution is conducted through the Fagron Shop e-commerce platform (shop.fagron.us), toll-free phone sales at 800-423-6967, and direct account-based B2B sales relationships.

The business model is a one-time product-sale B2B distribution model with quote-based or account-managed pricing that is not publicly disclosed. Customers register through the web shop or new customer registration process, and revenue is generated across multiple product categories with both short-dated promotional items and full-line catalog offerings. Letco maintains VAWD (Verified Accredited Wholesale Distributors) certification through the NABP, satisfying regulatory requirements for participation in the prescription drug supply chain. The company is headquartered at 201 W. 5th Street, Suite 1250, Austin, Texas, with 51-100 employees, and is led by CEO Douglas Bowman and CFO Todd Way. There is no public revenue disclosure, no disclosed funding activity, and no AI/ML capability footprint documented in the available data.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersDecatur, United States
HQ citystring
Decatur
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical compounding supplies, compounding chemicals, pharmaceutical equipment, cleanroom supplies, compounding capsules
Industry3 codes
1Small-Molecule API & Intermediates CDMO
CodeHLAGABAAPrimaryYes
2Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
CodeHLAGAHAMPrimaryNo
3Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
CodeHLAGABABPrimaryNo
NAICS code2 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Pharmaceutical Preparation Manufacturing325412
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Compounding Supplies
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Ingredient and Supply Sales
TypeOne Time License
Description

Letco generates revenue through the sale of pharmaceutical chemicals, APIs, bases, vehicles, capsules, equipment, and supplies to compounding pharmacies. As an affiliate of Fagron North America operating under the Fagron Shop e-commerce platform, the company serves B2B customers through direct web-based ordering, phone sales, and established customer accounts. Revenue is derived from product sales across multiple categories including chemicals, capsules, equipment, and cleanroom supplies.

shop.fagron.us
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Letco (also known as Letco Med or Letco Medical) is a B2B pharmaceutical compounding supply distributor operating as an affiliate of Fagron North America. The company sells pharmaceutical chemicals, APIs, bases, vehicles, capsules, compounding equipment, and cleanroom supplies to licensed compounding pharmacies through the Fagron Shop e-commerce platform, direct phone sales, and account-based B2B relationships. The company was founded in 1993 and is headquartered in Austin, Texas.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Letco (also known as Letco Med or Letco Medical) is an affiliate of Fagron North America, operating within the compounding pharmacy supply industry. As part of the Fagron ecosystem, Letco offers access to pharmaceutical compounding ingredients and supplies including chemicals, APIs, bases, vehicles, capsules, equipment, and cleanroom supplies. The specific product portfolio is offered through the Fagron Shop e-commerce platform, with Letco's customer accounts handled alongside Fagron's U.S. operations.

Product and service9 records
1Chemicals & APIs
CategoryPharmaceutical Ingredients
Description

Pharmaceutical-grade chemicals and active pharmaceutical ingredients (APIs) including colorants, controlled substances, and flavors, sold to licensed compounding pharmacies for use in customized medication preparation.

2Bases & Vehicles
CategoryCompounding Excipients
Description

Pharmaceutical compounding bases and vehicles including capsule excipients/fillers, creams, gels/foams/ointments, oral suspensions, suppositories, and troches & lollipops, supplied to compounding pharmacies for non-sterile and sterile drug preparation.

3Capsules
CategoryCapsule Supplies
Description

Empty pharmaceutical capsules in veggie and gelatin forms across sizes 0 through 5, sold to compounding pharmacies for encapsulation of customized formulations.

4Compounding Equipment
CategoryPharmacy Equipment
Description

Pharmacy compounding equipment including FagronLab branded products, autoclaves, balances and scales, capsule machines, hoods, mills, ovens, washers, hotplates/stirrers, and mixers, sold to compounding pharmacies for production operations.

5Cleanroom Supplies
CategoryCleanroom Consumables
Description

Cleanroom consumables including cleaners, crimpers and decappers, sterile devices (filters, seals and stoppers, sterile droppers, sterile syringes, sterile and non-sterile vials), and sterile PPE, supplied to compounding pharmacies for sterile compounding operations.

6Personal Protective Equipment (PPE)
CategorySafety Supplies
Description

Personal protective equipment including booties, bouffant and beard covers, gloves, gowns and coveralls (including chemo-rated USP 800), and masks for use in compounding pharmacy operations.

7Dispensing Devices
CategoryDispensing Packaging
Description

Dispensing devices including bottles, jars, molds, syringes, Topi-CLICK® (35, 140, Micro, Perl, and accessories), Topi-Pump, tubes, and UnoDose™ for use in pharmaceutical compounding and patient dispensing.

8Labware
CategoryLaboratory Supplies
Description

General laboratory supplies including cleaners and wipers, glassware, lab safety items, pH testing supplies, plastic bags, scoops/spoons/spatulas, thermometers, and weigh boats and paper, for use in compounding pharmacy laboratories.

9Short-Dated Products & Promotions
CategoryPromotional Inventory
Description

Discounted pharmaceutical ingredients and supplies with approaching expiration dates offered to compounding pharmacy customers for cost savings on otherwise standard inventory items.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Letco (also known as Letco Med or Letco Medical) operates as an affiliate of Fagron North America. This is a corporate affiliation within the Fagron Group, a global leader in pharmaceutical compounding solutions. Letco's products are sold through the Fagron Shop e-commerce platform (shop.fagron.us), and the company leverages Fagron's brand, distribution infrastructure, and supply chain capabilities. The affiliation enables Letco to serve the U.S. compounding pharmacy market with access to Fagron's comprehensive product portfolio and operational resources.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Medisca is a global supplier of pharmaceutical compounding ingredients, bases, vehicles, and equipment, serving compounding pharmacies with a comparable product catalog and B2B distribution model. Its scale and international footprint make it a closely comparable direct competitor to Letco in the U.S. compounding channel.

TypeBroad incumbent
Description

McKesson is one of the largest U.S. pharmaceutical wholesalers and a major distributor of drugs, APIs, and related supplies. While not specializing in compounding, its scale and existing supplier relationships position it as a credible potential entrant or broad competitor in the specialty compounding supply channel.

TypeDirect peer
Description

PCCA is the largest U.S. distributor of pharmaceutical compounding ingredients, bases, and equipment to independent compounding pharmacies. It competes head-to-head with Letco across APIs, excipients, capsules, and compounding equipment for the same compounding pharmacy customer base.

TypeBroad incumbent
Description

Cardinal Health is a major U.S. pharmaceutical distributor with significant wholesale and specialty distribution operations. While its core focus is broader pharmaceutical distribution, its specialty and at-home solutions businesses overlap with portions of Letco's compounding supply value chain.

TypeBroad incumbent
Description

Fagron NV is the publicly listed parent of Fagron North America (and effectively Letco's parent). It is a global leader in pharmaceutical compounding with operations across North America, Europe, Latin America, and other regions, offering a broader portfolio of compounding services and finished products than Letco's U.S.-focused distribution business.

TypeBroad incumbent
Description

Cencora is a top-tier U.S. pharmaceutical distributor serving retail, hospital, and specialty pharmacy channels. Its specialty distribution capabilities and global sourcing infrastructure create overlapping reach with Letco's compounding pharmacy customer base, particularly for APIs and excipients.

TypeOthers
Description

Acme-Hardesty is a specialty ingredients distributor supplying oleochemicals and pharmaceutical-grade excipients to industrial and healthcare customers. While not a dedicated compounding pharmacy supplier, it overlaps with Letco in select excipient and base categories serving adjacent pharmaceutical customers.

TypeDirect peer
Description

Spectrum Chemical operates a dedicated pharmacy products division supplying APIs, excipients, and compounding supplies to compounding pharmacies. Its catalog breadth across chemicals and pharmaceutical-grade ingredients directly overlaps with Letco's chemicals/APIs and bases/vehicles offerings.

TypeDirect peer
Description

Humco manufactures and distributes pharmaceutical compounding ingredients, vehicles, and OTC products to compounding pharmacies and the broader healthcare market. It competes with Letco on bases, vehicles, and select APIs serving similar compounding pharmacy customers.

TypeEmerging player
Description

Roquette is a global manufacturer of pharmaceutical excipients (cyclodextrins, starches, polyols) increasingly used in compounding formulations. While primarily an excipient manufacturer rather than a full-line compounding distributor, it represents an upstream adjacent player competing for a share of the bases/vehicles wallet that Letco serves.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Letco

Pharmaceutical Compounding Suppliesletcomedical.com

What Letco does

Letco (also operating as Letco Med or Letco Medical) is a U.S. pharmaceutical ingredient and compounding supply distributor founded in 1993, operating as an affiliate of Fagron North America. The company sells pharmaceutical-grade chemicals, active pharmaceutical ingredients (APIs), bases and vehicles, capsules, compounding equipment, cleanroom supplies, personal protective equipment (PPE), and specialized dispensing devices to licensed compounding pharmacies and compounding laboratories across the United States. Its product portfolio spans more than a dozen categories including controlled substances, flavors, colorants, excipients, sterile devices (vials, filters, syringes), and branded dosing systems such as Topi-CLICK and Topi-Pump. Distribution is conducted through the Fagron Shop e-commerce platform (shop.fagron.us), toll-free phone sales at 800-423-6967, and direct account-based B2B sales relationships.

The business model is a one-time product-sale B2B distribution model with quote-based or account-managed pricing that is not publicly disclosed. Customers register through the web shop or new customer registration process, and revenue is generated across multiple product categories with both short-dated promotional items and full-line catalog offerings. Letco maintains VAWD (Verified Accredited Wholesale Distributors) certification through the NABP, satisfying regulatory requirements for participation in the prescription drug supply chain. The company is headquartered at 201 W. 5th Street, Suite 1250, Austin, Texas, with 51-100 employees, and is led by CEO Douglas Bowman and CFO Todd Way. There is no public revenue disclosure, no disclosed funding activity, and no AI/ML capability footprint documented in the available data.

Letco firmographics

Firmographics
Name
Letco
Legal name
Letco
Website
https://letcomedical.com
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

Letco industry classification

Industry
Product category
Pharmaceutical Compounding Supplies
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry
Small-Molecule API & Intermediates CDMO (HLAGABAA)
akta.pro secondary industries
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

Keywords

  • Pharmaceutical compounding supplies
  • Compounding chemicals
  • Pharmaceutical equipment
  • Cleanroom supplies
  • Compounding capsules

Where Letco is headquartered

Location

Headquarters

HQ city
Decatur
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Letco business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Pharmaceutical Ingredient and Supply Sales: Letco generates revenue through the sale of pharmaceutical chemicals, APIs, bases, vehicles, capsules, equipment, and supplies to compounding pharmacies. As an affiliate of Fagron North America operating under the Fagron Shop e-commerce platform, the company serves B2B customers through direct web-based ordering, phone sales, and established customer accounts. Revenue is derived from product sales across multiple categories including chemicals, capsules, equipment, and cleanroom supplies.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Letco product offering

Product offering

Core offering

Letco (also known as Letco Med or Letco Medical) is a B2B pharmaceutical compounding supply distributor operating as an affiliate of Fagron North America. The company sells pharmaceutical chemicals, APIs, bases, vehicles, capsules, compounding equipment, and cleanroom supplies to licensed compounding pharmacies through the Fagron Shop e-commerce platform, direct phone sales, and account-based B2B relationships. The company was founded in 1993 and is headquartered in Austin, Texas.

Product overview

Letco (also known as Letco Med or Letco Medical) is an affiliate of Fagron North America, operating within the compounding pharmacy supply industry. As part of the Fagron ecosystem, Letco offers access to pharmaceutical compounding ingredients and supplies including chemicals, APIs, bases, vehicles, capsules, equipment, and cleanroom supplies. The specific product portfolio is offered through the Fagron Shop e-commerce platform, with Letco's customer accounts handled alongside Fagron's U.S. operations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Chemicals & APIs Pharmaceutical-grade chemicals and active pharmaceutical ingredients (APIs) including colorants, controlled substances, and flavors, sold to licensed compounding pharmacies for use in customized medication preparation.
  • Bases & Vehicles Pharmaceutical compounding bases and vehicles including capsule excipients/fillers, creams, gels/foams/ointments, oral suspensions, suppositories, and troches & lollipops, supplied to compounding pharmacies for non-sterile and sterile drug preparation.
  • Capsules Empty pharmaceutical capsules in veggie and gelatin forms across sizes 0 through 5, sold to compounding pharmacies for encapsulation of customized formulations.
  • Compounding Equipment Pharmacy compounding equipment including FagronLab branded products, autoclaves, balances and scales, capsule machines, hoods, mills, ovens, washers, hotplates/stirrers, and mixers, sold to compounding pharmacies for production operations.
  • Cleanroom Supplies Cleanroom consumables including cleaners, crimpers and decappers, sterile devices (filters, seals and stoppers, sterile droppers, sterile syringes, sterile and non-sterile vials), and sterile PPE, supplied to compounding pharmacies for sterile compounding operations.
  • Personal Protective Equipment (PPE) Personal protective equipment including booties, bouffant and beard covers, gloves, gowns and coveralls (including chemo-rated USP 800), and masks for use in compounding pharmacy operations.
  • Dispensing Devices Dispensing devices including bottles, jars, molds, syringes, Topi-CLICK® (35, 140, Micro, Perl, and accessories), Topi-Pump, tubes, and UnoDose™ for use in pharmaceutical compounding and patient dispensing.
  • Labware General laboratory supplies including cleaners and wipers, glassware, lab safety items, pH testing supplies, plastic bags, scoops/spoons/spatulas, thermometers, and weigh boats and paper, for use in compounding pharmacy laboratories.
  • Short-Dated Products & Promotions Discounted pharmaceutical ingredients and supplies with approaching expiration dates offered to compounding pharmacy customers for cost savings on otherwise standard inventory items.

Companies that use Letco

Customer profile

Segments2 records

Ideal customer profiles2 records

Letco technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Letco partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Fagron North AmericacoreOthersLetco (also known as Letco Med or Letco Medical) operates as an affiliate of Fagron North America. This is a corporate affiliation within the Fagron Group, a global leader in pharmaceutical compounding solutions. Letco's products are sold through the Fagron Shop e-commerce platform (shop.fagron.us), and the company leverages Fagron's brand, distribution infrastructure, and supply chain capabilities. The affiliation enables Letco to serve the U.S. compounding pharmacy market with access to Fagron's comprehensive product portfolio and operational resources.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Letco competitors and assessment

Company assessment

Direct peers

  • Medisca: Medisca is a global supplier of pharmaceutical compounding ingredients, bases, vehicles, and equipment, serving compounding pharmacies with a comparable product catalog and B2B distribution model. Its scale and international footprint make it a closely comparable direct competitor to Letco in the U.S. compounding channel.
  • PCCA (Professional Compounding Centers of America): PCCA is the largest U.S. distributor of pharmaceutical compounding ingredients, bases, and equipment to independent compounding pharmacies. It competes head-to-head with Letco across APIs, excipients, capsules, and compounding equipment for the same compounding pharmacy customer base.
  • Spectrum Pharmacy Products (Spectrum Chemical): Spectrum Chemical operates a dedicated pharmacy products division supplying APIs, excipients, and compounding supplies to compounding pharmacies. Its catalog breadth across chemicals and pharmaceutical-grade ingredients directly overlaps with Letco's chemicals/APIs and bases/vehicles offerings.
  • Humco Holding Group: Humco manufactures and distributes pharmaceutical compounding ingredients, vehicles, and OTC products to compounding pharmacies and the broader healthcare market. It competes with Letco on bases, vehicles, and select APIs serving similar compounding pharmacy customers.

Broad incumbents

  • McKesson: McKesson is one of the largest U.S. pharmaceutical wholesalers and a major distributor of drugs, APIs, and related supplies. While not specializing in compounding, its scale and existing supplier relationships position it as a credible potential entrant or broad competitor in the specialty compounding supply channel.
  • Cardinal Health: Cardinal Health is a major U.S. pharmaceutical distributor with significant wholesale and specialty distribution operations. While its core focus is broader pharmaceutical distribution, its specialty and at-home solutions businesses overlap with portions of Letco's compounding supply value chain.
  • Fagron NV: Fagron NV is the publicly listed parent of Fagron North America (and effectively Letco's parent). It is a global leader in pharmaceutical compounding with operations across North America, Europe, Latin America, and other regions, offering a broader portfolio of compounding services and finished products than Letco's U.S.-focused distribution business.
  • Cencora (formerly AmerisourceBergen): Cencora is a top-tier U.S. pharmaceutical distributor serving retail, hospital, and specialty pharmacy channels. Its specialty distribution capabilities and global sourcing infrastructure create overlapping reach with Letco's compounding pharmacy customer base, particularly for APIs and excipients.

Others

  • Acme-Hardesty: Acme-Hardesty is a specialty ingredients distributor supplying oleochemicals and pharmaceutical-grade excipients to industrial and healthcare customers. While not a dedicated compounding pharmacy supplier, it overlaps with Letco in select excipient and base categories serving adjacent pharmaceutical customers.

Emerging players

  • Roquette (Pharmaceutical Excipients): Roquette is a global manufacturer of pharmaceutical excipients (cyclodextrins, starches, polyols) increasingly used in compounding formulations. While primarily an excipient manufacturer rather than a full-line compounding distributor, it represents an upstream adjacent player competing for a share of the bases/vehicles wallet that Letco serves.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Letco social profiles

Digital presence

Letco compliance and trust

Trust signal

Compliance1 record

Letco financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Letco leadership team

Management profile

Number of profiles

Profiles2 records

Letco funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Letco M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Letco

What does Letco do?

Letco (also known as Letco Med or Letco Medical) is a B2B pharmaceutical compounding supply distributor operating as an affiliate of Fagron North America. The company sells pharmaceutical chemicals, APIs, bases, vehicles, capsules, compounding equipment, and cleanroom supplies to licensed compounding pharmacies through the Fagron Shop e-commerce platform, direct phone sales, and account-based B2B relationships. The company was founded in 1993 and is headquartered in Austin, Texas.

Is Letco a public or private company?

Letco is a private company. It is classified as corporate owned and is currently operating.

When was Letco founded?

Letco was founded in 1993. It employs 51 to 100 people.

Where is Letco based?

Letco is headquartered in Decatur, United States, in the North America region.

How does Letco make money?

One revenue line is on record: pharmaceutical Ingredient and Supply Sales.

Who are Letco's main competitors?

Direct peers on record are Medisca, PCCA (Professional Compounding Centers of America), Spectrum Pharmacy Products (Spectrum Chemical) and Humco Holding Group. Broad incumbents are McKesson, Cardinal Health, Fagron NV and Cencora (formerly AmerisourceBergen). Acme-Hardesty is listed as an others. Roquette (Pharmaceutical Excipients) is listed as an emerging player.

Does Letco have an API?

No public API is recorded for Letco.

What industry is Letco in?

Letco's product category is Pharmaceutical Compounding Supplies. Its primary akta.pro industry code is HLAGABAA, Small-Molecule API & Intermediates CDMO, with a secondary code of HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 3254 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireLetco Medical, LLC Partners with Specialty Process Labs to Distribute US-Manufactured Thyroid USPLetco Medical, LLC has partnered with Specialty Process Labs (SPL Labs) to become the only authorized US distributor of Thyroid USP for compounding pharmacies, after more than a year of due diligence on multiple manufacturers. SPL Labs is notable as the only API manufacturer producing Thyroid USP in a US-based cGMP-compliant facility, with all porcine ingredients sourced in North America, eliminating the supply chain risks associated with thyroid products sourced from other countries. Letco Med conducted extensive audits and third-party laboratory testing to validate SPL Labs' quality and homogeneity before finalizing the partnership.PR NewswireLetco Med and Fourth Power Labs Partner to Bring Hemp-Derived, THC-Free CBD Products to Compounding Pharmacies and their PatientsLetco Medical, LLC announced an exclusive partnership with Fourth Power Labs to distribute the CBD company's broad spectrum THC-free products to the independent compounding pharmacy marketplace. The partnership gives Letco Med access to Fourth Power Labs' formulations, which are developed by Ph.D. scientists and tested by Eurofins, while Fourth Power Labs gains access to Letco Med's established base of compounding pharmacy customers and dedicated salesforce. Fourth Power Labs products are now available through Letco Med's website and sales team.PR NewswireLetco Medical Announces Multi-Year Contribution to the Alliance for Pharmacy Compounding to Protect Patient Access for Compounded Hormone Replacement TherapiesLetco Medical announced a three-year financial commitment of over $100,000 to fund the Alliance for Pharmacy Compounding's nationwide advocacy campaign to protect patient access to compounded bioidentical hormone therapies. The company will also launch a new partnership program on July 1, 2021, enabling its pharmacy customers to directly fund APC's advocacy efforts by sharing a portion of order revenues. Letco Med, headquartered in Wayne, PA, has positioned itself as the first APC corporate member to make a multi-year commitment to this campaign.PR NewswireLetco Medical, LLC Partners With FedEx® to Provide Free Next Day Delivery on All Customer Orders for the Remainder of 2020Letco Medical, LLC announced a partnership with FedEx to provide free next-day delivery on all US customer orders through January 1, 2021, to address anticipated shipping delays during the 2020 holiday season. The company cited predictive data modeling showing exponential increases in small parcel package volumes driven by COVID-19-related consumer and business behaviors. Letco Med expects to send 20,000 packages via next-day delivery as part of the program, serving independent pharmacy, hospital, government, and chain store customers.PR NewswireLetco Medical Supports FDA's Statement Regarding The Proper Use Of Compounded Medication IngredientsLetco Medical publicly supported the FDA's June 7, 2019 statement on proper use of bulk ingredients for compounded sterile injectable dosage forms, responding to adverse events linked to a compounded formulation prepared by Enovex Pharmacy using Letco's dietary supplement ingredient L-glutathione. The FDA completed a comprehensive 14-day audit of Letco's registered Alabama repackaging facility on May 20, 2019, issuing no Form 483 inspection observations, indicating no regulatory violations. Enovex Pharmacy voluntarily initiated a recall of the 200 mg/mL L-glutathione sterile injectable product on January 11, 2019, though no recall of Letco's bulk ingredient was requested or occurred.PR NewswireLetco Med Announces The Launch Of A New Industry-Leading Website And E-Commerce Solution Making It Easier For Compounding Pharmacies To Do BusinessLetco Medical, L.L.C. (Letco Med), a Pennsylvania-based supplier of compounding products, launched a new web-based e-commerce platform on April 11, 2019, designed to streamline ordering and self-service for compounding pharmacies. The platform provides features including product search, expanded shipping options, account-specific pricing, and access to compounding formulas, documentation, and delivery tracking. Letco Med partnered with Blue Fountain Media, a Pactera Company, to develop the solution, which the company describes as the most advanced web-based ordering platform in the compounding industry.PR NewswireLetco Med and Ananda Professional Partner to Bring CBD and Education to Compounding PharmaciesLetco Medical, LLC (Letco Med) and Ananda Professional announced an exclusive partnership to bring hemp-derived CBD products to compounding pharmacies across the United States. The partnership, facilitated by the 2018 Farm Bill's removal of hemp from the Controlled Substances Act, grants compounding pharmacies access to Ananda Professional's product line alongside educational support and a dedicated coach to help integrate CBD therapies into patient care. Market projections from Brightfield Group indicate the CBD market is growing approximately 50% year-over-year, rising from $500 million in 2018 sales to an estimated $22 billion by 2022.PR NewswireLetco Medical, L.L.C. Announces Exclusive Partnership with Sweetgrass GxP Group, L.L.C. to Launch Regulatory Solutions Program for Compounding PharmaciesLetco Medical announced an exclusive partnership with Sweetgrass GxP Group to launch a Regulatory Solutions Program for compounding pharmacies, providing services including USP compliance assessments, training programs, and quality assurance for 503A and 503B pharmacies. The program establishes what the companies claim is a new industry benchmark for regulatory service delivery at competitive price points, with an introductory 20% discount offered through the remainder of 2018. Both companies emphasize the growing need for enhanced regulatory compliance services in the compounding pharmacy sector as the key driver behind this collaboration.PR NewswireLetco Medical, L.L.C. Acquired by Current Management TeamLS2, LLC, comprised of Letco Medical's current management team, has acquired all outstanding shares of Letco Medical from private equity firm Court Square Capital Partners. The acquisition makes the company fully employee-owned; the management team had been running Letco's day-to-day operations since January 2017 after previously leading Harvard Drug Group. The new ownership team has committed to continuing investments in technology, customer programs, and strategic acquisitions while maintaining the company's focus on the U.S. compounding pharmacy market.PR NewswireLetco Medical, L.L.C. Announces Launch of New, Industry-Leading Product Labeling Solution for Compounding PharmaciesLetco Medical, L.L.C. announced the launch of a new industry-leading product labeling solution for compounding pharmacies on March 28, 2018, coinciding with the introduction of Oxytocin USP to the compounding market. The redesigned labels feature improved readability, NIOSH chemical identification, OSHA/GHS compliance elements, and DEA schedule badging for controlled substances, developed through collaboration with branding agency Damen Jackson following customer feedback and focus group testing. The company states the new labels are intended to reduce medication and formulation errors while enhancing worker safety in pharmacy environments.